Arkolith/Insider Trading/CRVS/Form 4

Miller Richard A MD

President and CEO, DirectorCorvus Pharmaceuticals, Inc. (CRVS) · full profile →Form 4 · filed May 9, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 7, 2025Option exercise(M)559K$3.50$2.0M1.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 7, 2025Option exercise(M)559K——0

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-25-000115) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML